Cresco Labs (CRLBF) Income from Non-Controlling Interests (2020 - 2026)

Cresco Labs (CRLBF) reported Income from Non-Controlling Interests of -$3.9 million for Q1 2026, down 391.52% on a YoY basis from $1.4 million in Q1 2025, and down 189.64% quarter-over-quarter from -$1.4 million in Q4 2025.

Cresco Labs (CRLBF) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends

Cresco Labs has reported Income from Non-Controlling Interests for 7 years, with the latest figure at -$3.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 391.52% year-over-year to -$3.9 million; the trailing twelve-month figure through Mar 2026 stood at -$7.8 million (down 177.69% YoY), and the FY2025 full-year result was -$4.6 million, down 133.24% from the prior year.
  • Income from Non-Controlling Interests for Q1 2026 stood at -$3.9 million, down from -$1.4 million in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $6.5 million in Q3 2022, with the low at -$19.3 million in Q4 2022.
  • Historically, Income from Non-Controlling Interests has averaged -$162058.8 across 5 years, with a median of $2.2 million in 2023.
  • Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests slumped 783.66% — and 2024, when it surged 278.19%.
  • Cresco Labs' Income from Non-Controlling Interests stood at -$19.3 million in 2022, then soared by 111.58% to $2.2 million in 2023, then surged by 115.45% to $4.8 million in 2024, then tumbled by 128.29% to -$1.4 million in 2025, then sank by 189.64% to -$3.9 million in 2026.
  • The last three Income from Non-Controlling Interests figures came in at -$3.9 million (Q1 2026), -$1.4 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 22.56 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn -
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn -
10 Cresco Labs - - 75.45 Mn -3.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.94 Mn
Dec 31, 2025 -1.36 Mn
Sep 30, 2025 -4.91 Mn
Jun 30, 2025 2.44 Mn
Mar 31, 2025 -802,000.00
Dec 31, 2024 4.81 Mn
Sep 30, 2024 2.85 Mn
Jun 30, 2024 3.15 Mn
Mar 31, 2024 3.14 Mn
Dec 31, 2023 2.23 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 -6.93 Mn
Mar 31, 2023 -1.76 Mn
Dec 31, 2022 -19.29 Mn
Sep 30, 2022 6.54 Mn
Jun 30, 2022 5.25 Mn
Mar 31, 2022 3.71 Mn
Dec 31, 2021 2.82 Mn
Sep 30, 2021 7.19 Mn
Jun 30, 2021 7.48 Mn